about
Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidIntravital Microscopy Imaging Approaches for Image-Guided Drug Delivery SystemsCapillary collagen as the physical transport barrier in drug delivery to tumor microenvironment.Multistage vector (MSV) therapeutics.Polymeric oncolytic adenovirus for cancer gene therapy.Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro.Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluationOvercoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs.Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.Magnetic nanoparticle clusters radiosensitise human nasopharyngeal and lung cancer cells after alternating magnetic field treatment.Towards personalized medicine: chemosensitivity assays of patient lung cancer cell spheroids in a perfused microfluidic platform.Barriers to Liposomal Gene Delivery: from Application Site to the Target.Protein based therapeutic delivery agents: Contemporary developments and challenges.Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunitiesComplex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acidMediating Passive Tumor Accumulation through Particle Size, Tumor Type, and Location.Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.Dually responsive mesoporous silica nanoparticles regulated by upper critical solution temperature polymers for intracellular drug delivery.Biomimetic microfluidic platform for the quantification of transient endothelial monolayer permeability and therapeutic transport under mimicked cancerous conditions.Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma.Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells.Polysaccharides for the Delivery of Antitumor Drugs.Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicinesPrior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumorA Robust Design for Cellular Vehicles of Gold Nanorods for Multimodal ImagingImpact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells
P2860
Q26799981-22F3D546-09E3-4981-82A0-15F2D115DECFQ28553638-B9021DD3-C543-4D3A-8A1B-368B12A88761Q36072635-869A3149-7108-4C25-8E3B-E1DD4473EB3FQ36307634-C77297FE-1F08-4898-B619-064705F9AACBQ36344901-D1308FD3-D2A1-4EC2-B423-AB683BF8B1A6Q36396095-29042D22-5CD6-4DA0-89E3-AAB23C08AC61Q36857828-86DC1D7C-A211-4551-A67F-9B0A18555BB0Q36992161-F8DD8D76-9B66-4AC7-B86A-F3BFCF1A2889Q38713612-E9C35BB7-D92F-4F4D-B799-6474BE1705BDQ38776676-DB14410F-DC32-4550-B1BB-6E443C0EED36Q38834528-9835ECA0-5868-40CE-8953-B327CD83F902Q38862433-D7AE0AA1-9CDB-4F10-9275-612BC4D8872FQ39147224-2CA97924-4718-4C5C-A2D0-86DDDB3CCDBBQ39273739-BE8E65D4-422B-4D18-B192-D4547052BE53Q39306543-8B01FBE4-A5BD-4262-A7E6-9B4DC0F995FDQ39458957-ECA5FB58-F032-45E4-8A15-F8DE8AAD80F5Q41782832-F367AA33-D261-43FB-A40D-2D3DF316DB86Q44870836-7ADD28DD-F4D6-43CE-B521-9EEFB4045C52Q44933611-324B6920-BB61-4D27-8DEE-542C068EE11FQ47190264-BAFB7BC6-AA03-44D0-BF78-DB8E0C2F118FQ47241458-D33BD4CD-D8BA-4D69-A64E-CC5592E7465DQ47732809-ACA98537-43F2-4DCE-908E-464953AC298CQ48540669-48DC8A99-9214-4FC2-B07D-6D5D0322D0DAQ50102174-F5CED5C0-FECC-4949-813A-2C4FF36B5761Q50347968-938235CC-C477-407A-8F51-69F7555CCD13Q57073301-7ACE1925-2F42-465D-8002-F654493B2AA5Q57483726-84FC93E3-68B2-462F-A8CA-296EB02B81C4Q57730634-C4210C18-271E-4024-AB07-34A10D581183Q58771197-35F0FB87-E013-45E6-9662-246A1D5692C4
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Barriers to drug delivery in solid tumors.
@en
type
label
Barriers to drug delivery in solid tumors.
@en
prefLabel
Barriers to drug delivery in solid tumors.
@en
P2093
P2860
P356
P1433
P1476
Barriers to drug delivery in solid tumors.
@en
P2093
Bhawani Aryasomayajula
Shravan Kumar Sriraman
Vladimir P Torchilin
P2860
P304
P356
10.4161/TISB.29528
P577
2014-07-22T00:00:00Z